SentinelOne CEO sells 527,368 shares on October 5
Reported sale prices for the Class A shares ranged from $24.95 to $25.51.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SentinelOne, Inc. (S) President and CEO Tomer Weingarten exercised 500,000 stock options at a $9.74 exercise price for Class B shares on October 5, 2026, converted 500,000 Class B shares into Class A, and sold 527,368 Class A shares at a weighted-average $25.2642 per share. The sale was effected under a Rule 10b5-1 plan adopted July 2, 2026. An irrevocable trust held 423,629 Class B shares; Weingarten disclaimed beneficial ownership except to the extent of any pecuniary interest.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F5 | 500,000 | $0.00 | $0.00 |
| Exercise | Class B Common Stock F6, F7 | 500,000 | $0.00 | $0.00 |
| Conversion | Class B Common Stock F6, F7 | 500,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1 | 500,000 | $9.74 | $4.87M |
| Sale | Class A Common Stock F2, F3, F4 | 527,368 | $25.2642 | $13.32M |
| holding | Class B Common Stock F6, F7, F8 | -- | -- | -- |
Footnotes (8)
- F1. Represents the number of shares that were acquired upon conversion of Class B common stock to Class A common stock.
- F2. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2026.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.95 to $25.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
- F4. Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
- F5. The stock option is fully vested and exercisable. Pursuant to the grant agreement between the reporting person and the Issuer, it became fully vested on April 24, 2026.
- F6. Each share of Class B common stock is convertible into one share of Class A common stock at any time and will convert automatically upon certain transfers and upon the earlier of (i) the date specified by a vote of the holders of 66 2/3% of the then outstanding shares of Class B common stock, (ii) seven years from the effective date of the Issuer's initial public offering ("IPO"), (iii) the first date following the IPO on which the number of shares of outstanding Class B common stock (including shares of Class B common stock subject to outstanding stock options) held by the reporting person, including certain entities that the reporting person controls, is less than 25% of the number of shares of Class B common stock (including shares of Class B common stock subject to outstanding stock options) that the reporting person originally held as of the date of the IPO,
- F7. (continued from footnote 6) (iv) the date fixed by the Issuer's board of directors (the "Board"), following the first date following the completion of this offering when the reporting person is no longer providing services to the Issuer as an officer, employee, consultant or member of the Board, (v) the date fixed by the Board following the date, if applicable, on which the reporting person is terminated for cause, as defined in the Issuer's restated certificate of incorporation, and (vi) the date that is 12 months after the death or disability, as defined in the Issuer's restated certificate of incorporation, of the reporting person.
- F8. The securities reported in this row are held by an irrevocable trust over whose trustee the reporting person may exercise remove and replace powers. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
fully vested and exercisable financial
irrevocable trust regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.